<DOC>
	<DOCNO>NCT01702194</DOCNO>
	<brief_summary>The purpose study determine TD-1211 processed body .</brief_summary>
	<brief_title>TD-1211 IV/Oral Mass Balance Study</brief_title>
	<detailed_description>This study provide information regard metabolic pathway TD 1211 , need evaluation potential drug-drug interaction , need study special population absolute oral bioavailability TD-1211 . The administration radiolabeled drug necessary fully characterize rate route elimination TD 1211 , provide quantitative information disposition TD 1211 . The result study allow comprehensive comparison animal human route elimination metabolic profile TD 1211 .</detailed_description>
	<criteria>1 . Healthy , nonsmoking male , 18 50 year old , inclusive . 2 . Agrees use highly effective method birth control . 3 . Body mass index ( BMI ) 19 30 kg/m2 , inclusive , weigh least 55 kg . 4 . Willing able give write informed consent . 1 . Evidence history clinically significant allergic ( except untreated , asymptomatic , seasonal allergy time dose ) , hematological , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurological disease . 2 . Hemoglobin &lt; 14.1 g/dL hematocrit &lt; 40.6 % Screening . 3 . History hypersensitivity drug , history current clinically significant hypersensitivity . 4 . Any condition possibly affect drug absorption ( e.g. , previous surgery gastrointestinal tract [ include removal part stomach , bowel , liver , gall bladder , pancreas ] ) . 5 . Participated another clinical trial investigational drug ( medical device ) within 60 day ( 5 halflives investigational drug , whichever long ) prior Screening , currently participate another trial investigational drug ( medical device ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>OIC</keyword>
	<keyword>Opioid Induced Constipation</keyword>
	<keyword>Constipation</keyword>
</DOC>